DNA Repair Drugs Market
According to Intent Market Research, the DNA Repair Drugs Market is expected to grow from USD 7.9 billion in 2023 at a CAGR of 14.4% to touch USD 20.2 billion by 2030. The DNA Repair Drugs Market is dominated by key players such as Amgen Inc., AstraZeneca, Bristol-Myers Squibb Company, Eli Lilly and Company, Gilead Sciences, Inc. and Merck KGaA.